ASCO GU 2023 Conference Coverage


 

FDA Announcement Based on the MAGNITUDE Trial: Niraparib With Abiraterone Acetate and Prednisone in Patients With mCRPC and Homologous Recombination Repair Gene Alterations

197 views
February 28, 2023
Comments 0
Login to view comments. Click here to Login